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Introduction:  Surgical  lung  biopsy  is  a  technique  that  presents  a  morbi-mortality  rate  of  con-
siderable  importance.  We  analyze  our  experience  with  surgical  lung  biopsies  for  the  diagnosis
of diffuse  lung  disease  and  the  effect  produced  on  the  indications  for  surgical  biopsy  in  these
pathologies  after  the  publication  of  the  consensus  of  the  ATS  (American  Thoracic  Society)  and
ERS (European  Respiratory  Society)  for  Idiopathic  Pulmonary  Fibrosis  (IPF).
Patients  and  methods:  We  performed  a  retrospective  review  of  171  patients  operated  between
January  1997  and  December  2011.  We  divided  the  series  into  2  groups:  group  1  (operated
between  1997  and  2002)  and  group  2  (operated  between  2003  and  2011).  Suspected  pre-
operative diagnosis,  respiratory  status,  pathological  postoperative  diagnoses,  percentage  of
thoracotomies,  mean  postoperative  stay  and  perioperative  morbidity  and  mortality  were  ana-
lyzed.
Results: Group  1  consisted  of  99  patients  and  group  two  72.  The  most  frequent  postoperative
diagnoses  were:  usual  interstitial  pneumonia  and  extrinsic  allergic  alveolitis.  There  were  ten
(5.84%) deaths.  Death  was  caused  by  progressive  respiratory  failure  that  was  related  to  inter-
stitial lung  disease  in  7  (70%)  of  10  cases,  alveolar  haemorrhage  in  2  (20%)  and  heart  failure  in
1 (10%).
Conclusions: Since  the  publication  of  the  ATS  and  ERS  consensus  on  the  IPF,  we  have  observed
a noticeable  decrease  in  the  number  of  indications  for  surgical  lung  biopsy.  This  technique,
though simple,  has  a  considerable  morbidity  and  mortality.
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Biópsia  pulmonar  cirúrgica  na  doenc¸a pulmonar  difusa.  A  nossa  experiência
nos  últimos  15  anos
Resumo
Introduc¸ão:  A  biópsia  pulmonar  cirúrgica  é  uma  técnica  com  uma  morbimortalidade  não  negli-
genciável. Este  trabalho  resulta  da  experiência  adquirida  na  realizac¸ão  de  biópsias  pulmonares
cirúrgicas  para  o  diagnóstico  da  doenc¸a  pulmonar  intersticial  difusa,  bem  como  pelo  efeito
provocado  sobre  as  indicac¸ões  da  biópsia  cirúrgica  nesta  entidade,  após  a  publicac¸ão  do  con-
senso da  ATS  (American  Thoracic  Society)  e  da  ERS  (European  Respiratory  Society,  para  Fibrose
Pulmonar Idiopática  (FPI),  em  2000  e  2002.
Métodos:  Revisão  retrospectiva  de  171  doentes  intervencionados  entre  Janeiro  de  1997  e
Dezembro  de  2011.  A  série  de  doentes  foi  dividida  em  dois  grupos:  o  grupo  1  (operados  entre
1997 e  2002)  e  o  grupo  2  (operados  entre  2003  e  2011).  Os  registos  efectuados  foram  a  suspeita
diagnóstica  pré-operatória,  o  estado  respiratório,  o  diagnóstico  patológico  pós-operatório,  a
percentagem  de  toracotomias,  a  média  de  internamento  hospitalar,  além  da  morbilidade  e
mortalidade  intra-hospitalares.
Resultados: Grupo  1  constituído  por  99  doentes  e  o  grupo  2  por  72.  Os  diagnósticos  pós-
operatórios  mais  frequentes  foram  a  pneumonia  intersticial  usual  e  a  alveolite  alérgica
extrínseca.  Houve  10  mortes  (5,84%).  Em  7  (70%)  dos  10  casos,  a  morte  foi  causada  por
progressão da  insuﬁciência  respiratória  provocada  pela  doenc¸a  subjacente,  em  2  (20%)
por hemorragia  alveolar,  e  em  um  caso  (10%)  por  insuﬁciência  cardíaca.
Conclusões: Desde a  publicac¸ão  do  consenso  da  ATS  e  da  ERS  na  FPI,  observou-se  uma  clara
diminuic¸ão no  número  de  indicac¸ões  para  a  biópsia  pulmonar  cirúrgica.  Esta  técnica,  apesar  de
simples, tem  uma  considerável  morbilidade  e  mortalidade.
© 2012  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
Introduction
The  classiﬁcation  of  interstitial  lung  disease  (ILD)  includes
a  broad  and  heterogeneous  group  of  pathologies  under  a
common  clinical--radiological  context.1,2 Thoracic  surgery
plays  an  important  role  in  this  entity.3 Surgical  lung  biopsy
performed  with  minithoracothomy  or  video-assisted  thora-
coscopic  surgery  (VATS)  is  indicated  in  all  cases  where  a
speciﬁc  diagnosis  of  ILD  has  not  been  reached  after  less  inva-
sive  examinations,  but  it  is  not  a  technique  without  serious
complications.4,5
It  is  well  known  that  VATS  means  a  shorter  operating  time,
less  incidence  of  postoperative  complications  and  reduced
hospital  stay  in  regard  to  thoracotomy.6 Whether  it  should
be  performed  must  be  assessed  in  each  individual  case  and
will  depend  on  the  patient’s  clinical  status.
In  2000,  the  ATS  (American  Thoracic  Society)  and  the  ERS
(European  Respiratory  Society)  published  the  ﬁrst  interna-
tional  consensus  as  regards  the  diagnosis  and  treatment  of
Idiopathic  Pulmonary  Fibrosis  (IPF).7 Two  years  later,  the
classiﬁcation  of  ILD  was  modiﬁed  following  a  new  consensus
developed  by  the  two  societies.8 With  this  double  consen-
sus,  the  clinical  and  radiological  criteria  for  the  diagnosis
of  IPF  were  established  without  pathological  conﬁrmation.
There  are  4  major  criteria  and  4  minor  criteria.  Diagnosis  of
IPF  is  achieved  in  the  presence  of  the  4  major  criteria  and
at  least  3  minor.
Here  is  our  surgical  experience  in  the  diagnosis  of  ILD.  We
analyze  the  effect  produced  on  the  indications  of  the  surgi-
cal  lung  biopsy  in  this  group  of  entities  after  the  publication
of  the  consensus  of  ATS  and  ERS.
Patients and methods
We  conducted  a  retrospective  study  which  included
171  patients  operated  in  our  department  between  1997  and
2011  to  obtain  a  lung  biopsy  in  the  ILD  diagnosis  process.
These  patients  were  classiﬁed  in  two  groups:  those  oper-
ated  between  1997  and  2002  (group  1)  and  those  operated
between  2003  and  2011  (group  2).
To  divide  our  series  we  chose  year  2003  as  the  turning
point,  this  was  one  year  after  the  publication  of  the  last
consensus  of  the  ATS  and  ERS  on  ILD.7,8 We  think  that  this  is
long  enough  to  asses  the  inﬂuence  of  the  two  consensus  on
the  indications  of  surgical  lung  biopsy.
We  performed  a  right  or  left  VATS  by  means  2  or  3  ports
of  12  mm.  When  it  was  impossible  to  get  to  a collapsed  lung
or  when  the  patient  did  not  tolerate  clamping,  an  anterior
thoracotomy  was  performed.  Two  or  three  specimens  were
obtained  with  endostaplers.  The  assessed  variables  in  this
study  were:  preoperative  presumptive  diagnosis,  respira-
tory  status,  postoperative  histological  diagnosis,  approach,
mean  postoperative  hospital  stay,  postoperative  morbidity,
intraoperative  and  postoperative  mortality  and  causes.
Statistical  analysis  was  performed  using  Statistical
Package  for  Social  Sciences  version  9.0  for  Windows  (SPSS,
Chicago  IL,  USA).  Age  was  expressed  as  mean  and  standard
deviation  (SD).  All  other  categorical  variables  were  summa-
rized  as  counts  and  percentages.  Results  were  considered
to  be  signiﬁcant  if  p  was  less  than  0.05.  We  used  the  Chi-
squared  test  and  Fisher’s  exact  test  for  qualitative  variables.
For  quantitative  variables  we  used  the  Mann--Whitney  U
test.











Figure  1  Postoperative  histological  diagnosis  in  our  series.
UIP: usual  interstitial  pneumonia;  AIP:  acute  interstitial
pneumonia;  COP:  cryptogenic  organizing  pneumonia;  HL:  hon-
eycombing  lung.
Results
Of  the  171  patients,  82  (48%)  were  men  and  89  (52%)  were
women.  The  mean  age  was  57.29  years  (SD  13.46).  There
were  no  signiﬁcant  differences  with  regard  to  age  between
the  two  sexes.  Preoperative  FEV1  (%)  was  76.19  ±  21.96,  FVC
(%)  was  77.15  ±  23.57  and  DLCO  (%)  was  56.18  ±  16.66.
The  preoperative  presumptive  diagnosis  was:  ILD  with-
out  speciﬁcations  in  142  patients  (83.04%),  sarcoidosis  in
7  (4.09%),  extrinsic  allergic  alveolitis  in  7  (4.09%),  Wegener
disease  in  3  (1.75%),  Langerhans  cell  histiocytosis  in
3  (1.75%),  vasculitis  in  3  (1.75%),  drug-associated  ILD  in
2  (1.16%),  rheumatoid  lung  in  1  (0.58%),  lymphangi-
oleiomyomatosis  in  1  (0.58%),  ILD  and  respiratory  failure  in
1  (0.58%)  and  Gaucher’s  disease  in  1  (0.58%).
The  postoperative  histological  diagnosis  was:  usual  inter-
stitial  pneumonia  (UIP)  in  49  of  the  171  cases  (28.65%),
extrinsic  allergic  alveolitis  in  42  (24.56%),  nonspeciﬁc  alter-
ations  in  37  (21.63%),  honeycombing  lung  in  9  (5.26%),
sarcoidosis  in  8  (4.67%),  pneumoconiosis  in  4  (2.33%),  nor-
mal  lung  in  3  (1.75%),  cryptogenic  organizing  pneumonia
in  3  (1.75%),  acute  interstitial  pneumonia  in  3 (1.75%),
granulomatous  lymphomatosis  in  3  (1.75%),  carcinomatous
lymphangitis  in  2  (1.16%),  Langerhans  cell  histiocytosis  in
2  (1.16%),  Wegener  disease  in  1  (0.64%),  vasculitis  in  1
(0.58%),  deposit  disease  in  1  (0.58%),  cytomegalovirus  pneu-
monia  in  1  (0.58%),  bronchioalveolar  carcinoma  in  1  (0.58%),
aspergillosis  in  1  (0.58%).  The  diagnosis  was  made  based
on  the  light  microscopy  study.  Immunohistochemistry  tech-
niques  were  useful  in  12  of  the  171  cases  (Fig.  1).
Comparing  group  1  (operated  between  1997  and  2002)
and  group  2  (operated  between  2003  and  2011),  we  observed
a  decrease  in  the  number  of  indications  for  surgical  lung
biopsies.  In  the  ﬁrst  period  99  patients  were  operated,
while  in  the  second  period  72  patients  were  operated.  More-
over,  we  can  observe  that  from  year  2004  (two  years  after
publication  of  the  recommendations)  there  was  a  notice-
able  decrease  in  the  number  of  biopsies  performed  when  we
compare  the  results  with  the  previous  years  (Fig.  2).  Also,
when  we  compared  the  postoperative  diagnosis  between
both  groups,  we  observed  a  small  decrease  in  the  number
of  diagnoses  of  unspeciﬁc  biopsy  (28  in  group  1  and  9  in
group  2)  and  honeycombing  lung  (7  in  group  1  and  2  in  group
2)  (Fig.  3).
Of  the  171  cases,  6  (3.50%)  needed  a minithoracotomy
due  to  adhesions,  2  for  lack  of  collapsed  lung  (1.16%)  and  9
(5.26%)  due  to  patient  intolerance  to  one-lung  ventilation.
There  were  10  deaths  (5.84%)  between  0  and  33  days  after
surgery  (mean  7.67  days;  SD  10.82  days).  Differences  in  age
and  sex  among  these  10  patients  and  the  rest  of  the  series
were  not  statistically  signiﬁcant.  Causes  of  death  were  pro-
gression  in  respiratory  failure  due  to  underlying  disease  in
7  of  the  10  cases  (70%),  alveolar  haemorrhage  in  2  of  the
10  cases  (20%)  and  heart  failure  in  1  of  the  10  cases  (10%).
Intraoperative  mortality  was  nil.  Mortality  was  higher  in
the  group  of  patients  that  underwent  a  thoracotomy  (4  of
15  patients;  26.66%)  compared  with  the  group  of  VATS
(6  deaths  in  141  cases;  4.25%).  The  p  was  <0.005  (Fig.  4).
Also,  the  death  rate  in  group  1  was  (7  deaths)  compared
to  group  2  (3  deaths),  although  this  was  not  statistically
signiﬁcant.
The  mean  postoperative  stay  in  the  whole  series  was
6.12  days  (interquartile  range  3--6  days).  The  mean  stay
for  patients  that  underwent  a  thoracotomy  was  12  days  (SD
7.12)  versus,  5.02  (SD,  4.33)  for  those  operated  by  VATS
(p  <  0.05).
Discussion
Our  series  presents  demographic  characteristics  that  do  not
substantially  differ  from  those  described  by  Xaubet  et  al.
in  2004.9 In  their  study  of  23  centres  of  the  Spanish  terri-
tory  with  511  unselected  cases  for  surgical  indication,  these
authors  observed  an  average  age  of  61  years  old  with  a
slight  predominance  of  males  (ratio  male/female  1.2:1).
Our  results  present  an  average  age  of  57.29  years  old  and  a
male/female  ratio  of  1.08:1.
We  observed  a marked  decreased  in  the  number  of  biop-
sies  performed  from  2004.  We  attribute  this  to  the  published
clinical--radiological  criteria  for  the  diagnosis  of  IPF  without
histological  conﬁrmation.  This  fact  indicated  that  recom-
mendations  still  took  some  time  before  being  used  in  clinical
practise.  However,  we  must  admit  that  our  series  is  surgical,
and  we  cannot  demonstrate  whether  there  is  an  increase  in
patients  diagnosed  of  IPF  by  clinical  or  radiological  criteria.
Again,  comparing  our  results  with  the  series  of  Xaubet
et  al.,  there  are  important  differences  in  the  most  com-
mon  diagnoses:  sarcoidosis  represents  14.9%  in this  series,
whereas  in  our  study  it  only  represents  4.67%.9 In  the  review
of  epidemiological  studies  by  Demedts  et  al.,10 sarcoidosis
and  IPF  appear  as  the  most  common  ILD.  This  discrepancy
could  be  explained  by  the  increased  probability  of  a  diag-
nosis  of  sarcoidosis  before  reaching  a  surgical  biopsy.  The
clinical,  radiological  and  laboratory  data  provide  a  diagno-
sis  that  can  be  conﬁrmed  by  a  transbronchial  biopsy  with  a
high  diagnostic  proﬁtability.11,12 These  could  be  a  source  of
bias  in  a  surgical  series.  In  this  way,  Santillan-Doherty  et  al.
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Figure  2  Distribution  of  the  number  of  lung  biopsies  performed  between  1997  and  2011.  Notice  how  from  the  year  2004  (arrow)
there is  a  decreased  in  the  number  of  biopsies  performed.
got  a  diagnosis  of  sarcoidosis  in  only  2  cases  (3.71%)  of  the
60  lung  biopsies  performed  for  ILD  in  Mexico.4
By  contrast,  we  found  a  high  percentage  of  biopsies  with
the  diagnosis  of  extrinsic  allergic  alveolitis  (a  centrolobu-
lar  process  caused  by  the  exposure  to  organic  allergens)13 in
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Figure  3  Comparison  of  most  frequent  postoperative  diag-
nosis in  each  group.  UIP:  usual  interstitial  pneumoniae;  EAA:
extrinsic  allergic  alveolitis;  Unesp:  unespeciﬁc  biopsy;  HL:  hon-
eycombing  lung;  Sar:  sacoidosis.
could  be  related  to  the  higher  exposure  to  common  agents
in  a  rural  population.  Another  possible  explanation  could  be
the  greater  propensity  of  the  clinicians  to  request  a  histo-
logical  conﬁrmation  of  an  ILD  that  is  considered  ‘‘curable’’
and  this  carries  important  medicolegal  and  sociolegal
connotations.
Most  of  the  authors  consider  IPF  to  be  the  most  fre-
quent  ILD.  This  statement  is  consistent  with  the  28.65%  of
usual  interstitial  pneumonia  (UIP)  diagnosed  in  our  series.
Nevertheless,  we  cannot  say  that  all  these  patients  were
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Figure  4  Distribution  of  procedures  according  to  the
approach  and  associated  mortality.
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UIP  is  not  one-one.  In  other  words,  the  diagnosis  of  IPF
requires  the  clinical  exclusion  of  any  other  cause  of  UIP.2,7,8
This  information  was  not  available  to  us  in  the  majority
of  the  cases  since  83.04%  of  the  patients  were  referred
to  our  department  to  perform  a  biopsy  with  the  generic
diagnosis  of  ILD,  and  without  any  other  clinical  suspi-
cion.  This  means,  from  our  point  of  view,  an  inappropriate
practise  possibly  caused  by  overconﬁdence  in  the  his-
tological  study  that  could  explain  why  37  of  171  cases
(21.63%)  received  a  nonspeciﬁc  pathological  diagnosis.
Diagnosis  of  the  majority  of  ILD  is  based  on  using  light
microscopy  to  evaluate  the  proportion,  localization  and
timing  of  a  common  histological  pattern,  and  it  is  not
free  of  susceptibility.14 In  a  multicenter  study  pub-
lished  in  2001,  researchers  observed  a  15%  discrepancy
in  the  diagnosis  of  UIP  among  expert  pathologists.15 The
pathologist’s  interpretation  of  the  ﬁndings  will  be  more
precise  the  greater  his  knowledge  of  the  patient’s  clinical
condition.3,12,15 In  this  sense,  it  is  mandatory  to  optimize
the  communication  between  the  clinician,  surgeon  and
pathologist  in  order  to  obtain  the  maximum  beneﬁt  from
the  technique.  Similarly,  Sánchez-Varilla  et  al.16 found  dif-
ferences  between  the  diagnoses  reached  by  a  group  of
specialist  pathologists  as  opposed  to  others  without  special-
ization  in  10  (30.3%)  of  33  cases  of  ILD  studied.  Of  these,
9  were  (40.9%)  in  the  group  of  22  interstitial  idiopathic
pneumonias.
Another  crucial  factor  for  the  diagnostic  yield  of  a  lung
biopsy  is  the  quality  of  the  samples,  which  must  be  of
sufﬁcient  size  and  taken  in  the  appropriate  time  course
and  localization.  5.26%  of  the  biopsies  in  our  series  were
reported  as  honeycomb  lung.  This  again  means  a  non-
speciﬁc  diagnosis,  as  this  is  the  ﬁnal  pathway  of  multiple
ILD.
It  is  important  to  avoid  an  excessive  delay  of  the  biopsy
during  the  course  of  the  disease.  Thus,  we  could  reduce  the
number  of  inconclusive  histologies.  The  biopsies  obtained  in
advanced  disease  are  less  proﬁtable  and  frequently  lead  to
complications.8 In  addition,  when  selecting  optimal  areas
for  the  biopsy,  areas  of  high  honeycomb  in  the  computed
tomography  should  be  avoided.  Areas  of  ground  glass  are
preferred.3 Finally,  the  optimal  size  to  obtain  a  biopsy
also  depends  on  the  clinical  suspicion.12 This  shows,  once
again,  the  importance  of  the  collaboration  between  special-
ists.
Surgical  lung  biopsy  can  provide  different  types  of  infor-
mation  on  the  patient  with  ILD:  to  conﬁrm  a  speciﬁc
diagnosis  or  to  exclude  a  suspicion;  to  justify  experimental
treatments  or  those  with  signiﬁcant  side  effects;  to  estab-
lish  a  prognosis  or  analyze  the  response  to  a  treatment;  to
evaluate  the  indication  of  lung  transplantation  or  to  resolve
a  medicolegal  conﬂict.  .  . But  in  all  cases,  it  is  highly  impor-
tant  to  formulate  the  correct  clinical  question  and  never
forget  the  great  surgical  risk.11
In  conclusion,  the  new  clinical--radiological  criteria  for
the  diagnosis  of  IPF  published  in  2000  and  2002,  had  induced
a  marked  decrease  in  the  number  of  biopsies  performed  from
2004  in  our  series.  Surgical  lung  biopsy,  although  techni-
cally  simple,  has  a  non-negligible  morbidity  and  mortality  in
patients  that  suffer  ILD.  The  optimal  selection  of  the  cases
to  minimize  the  mortality  and  to  optimize  the  diagnostic
performance  is  essential.
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